Marama Labs opens US office in Boston
Marama Labs has officially opened its first US office at CIC Cambridge in Kendall Square, Boston, bringing CloudSpec closer to our rapidly growing community of customers across the United States.
Marama Labs’ flagship product CloudSpec has been adopted by many of the world’s leading pharmaceutical companies, alongside innovative biotech companies, developing RNA-based vaccines, gene therapies and other nanoparticle-based medicines.
Establishing a physical presence in the United States is a major step for Marama Labs in supporting our customers and embedding ourselves in the Boston life sciences eco-system.
The Boston office gives customers a place to experience CloudSpec firsthand and work closely with our technical team to solve their formulation characterisation challenges.
Kendall Square puts us at the center of one of the world’s leading life science ecosystems. Being surrounded by pharmaceutical companies, emerging biotechs, research institutions and technology startups creates more opportunities to exchange ideas, build partnerships and stay close to the scientists we serve.
“Opening our Boston office brings us closer to many of the scientists using CloudSpec,” said Brendan Darby, co-founder and CEO of Marama Labs. “It gives us a dedicated space to demonstrate our technology, collaborate with customers and provide faster, more direct support as our US customer base continues to grow.”
The office opening was supported by Enterprise Ireland, Ireland’s government agency responsible for the development of Irish enterprises in world markets. “We’re delighted to support Marama Labs as it expands its presence in the United States,” said Cepta Duffy of Enterprise Ireland, Ireland’s government agency responsible for the development of Irish enterprises in world markets. “Opening an office in the heart of the Boston Life Sciences ecosystem reflects both the growing demand for Marama’s technology and the company’s commitment to working closely with its biopharma customers. It is an exciting milestone for Marama and another strong example of Irish innovation making an impact globally.”
